Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group.
about
Chemotherapy for brain metastases from small cell lung cancerSecond-line chemotherapy for locally advanced or metastatic small cell lung cancerPhase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501Treatment for small cell lung cancer, where are we now?-a reviewResearch Progression of Maintenance Therapy in Small Cell Lung CancerTherapeutic procedure in small cell lung cancerPhase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.Effect of topotecan as second-line chemotherapy for small cell lung cancer patients with interstitial lung disease.Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer.Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis.Consolidative thoracic radiotherapy for extensive stage small cell lung cancerCorrelation between the efficacy of amrubicin and the previous chemotherapy regimen for relapsed small cell lung cancer.Novel systemic therapies for small cell lung cancerSmall cell lung cancer: therapies and targetsExtensive disease small cell lung cancer dose-response relationships: implications for resistance mechanisms.A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancerElectronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC.Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.Duration of chemotherapy for small cell lung cancer: a meta-analysis.Chinese herbal decoction based on syndrome differentiation as maintenance therapy in patients with extensive-stage small-cell lung cancer: an exploratory and small prospective cohort study.Febrile neutropenia in chemotherapy treated small-cell lung cancer patientsModified one-day etoposide and cisplatin combination for previously untreated extensive-disease small-cell lung cancer: A retrospective evaluation of 36 cases.Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study.Immunotherapy treatments for small-cell lung cancer: past, present and future.Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer.Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.Topotecan for the treatment of small-cell lung cancer.Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumorsCurrent concepts in the management of small cell lung cancer.A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer.Correlation between the sensitivity of tumors to treatment with CZ48 and local concentrations of the active metabolite CPT within the tumors.Update on new drugs in small cell lung cancer.Chemotherapy advances in small-cell lung cancerAdvances in pharmacotherapy of small cell lung cancer.Radiation Therapy in Extensive Stage Small Cell Lung Cancer.Recent developments in radiotherapy for small-cell lung cancer: a review by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).Maintenance sunitinib for extensive-stage small cell lung cancer: a new standard, an option or a step in the right direction?
P2860
Q24202771-CEA66756-6119-4917-AE2E-6DC8644D807EQ24241040-614D2D67-3731-4DFB-900C-5DDCEBB5F923Q24658198-E7D9936D-2C27-4338-9D37-5BF7DEF4F53AQ26767023-1D4D1F80-7DE1-4FA3-A999-4D4E81E645E7Q26783450-6A2513A5-46DB-4917-9DC9-F1A0F245569AQ26861330-63F685CA-2A70-4F4F-A0DE-C53C91F39E49Q33381874-391B88B7-09C9-454C-A20E-D25EDB3673F6Q33384024-DB762A64-47E2-4CEC-9934-CD9E73A6E64EQ33399107-1558D8E5-3706-492D-95C1-B6A883C24B4FQ33400716-F2C9FED9-561D-4F02-A354-AA32AB803BEBQ33420821-3114CE06-DDDF-4BFB-8054-27D7421459F3Q33443629-2756D6FA-FB9E-44E1-AFAF-51D0CAF1F7C6Q33591894-9DC3F92C-5401-4EE8-9577-CE05A3F7E33CQ33599044-B5EF7FBF-0A6B-456D-9892-A618D9302EE9Q33862245-F0BBBA36-B3A5-41D3-8209-901B6B7F6E6AQ34250859-AF3232C8-E409-4BD0-9111-47026ED0A86AQ34252309-CB485870-1171-4879-8E02-2DA0DD06A650Q34313435-569E83A6-7424-44F0-BD38-2813D7787A17Q34420379-255F98BA-64F6-409F-9556-7B0F7ACC4973Q34982142-8F8867E7-D639-4C13-92C3-3EABA9DD0386Q34983763-2CD4CADC-995B-4455-8F6E-1D6C225D1CC6Q35178092-4A12F3CA-F842-45A5-93E7-1F5DE7D86B2FQ35297079-396352CD-36F1-4E32-A60C-2C727D4775B2Q35802946-900718D7-C61B-4156-A9FF-B331CC6C7155Q35870332-2014E115-B8CF-4C5A-B5C7-93A1A1972171Q35904003-7ADFA717-4E6E-4D9F-8CE2-93A8784F9505Q36311998-E366C5E6-4361-40D3-A3B4-0E11B999D7DBQ36443757-54CD8F9D-C04C-4F09-9B26-2B035C868501Q36673526-8A05A142-EC91-493E-8C14-EC1DF0DE0DB6Q36842752-BEA0CFFF-9A19-42F1-A3B5-529B9204D020Q36879421-5CE41A85-2683-464F-961C-63C9006F1FC7Q37073202-930AB2F2-BE22-4C85-AC8D-E3B6286D0F98Q37491139-B17CD6A4-82FF-4727-94F8-324A5E4C1EF4Q37567633-7A5A519D-F6BA-4A98-BF44-EAEA2E648F25Q37851992-87070C5A-44F1-4085-A7FC-7278D64EDC8DQ38155856-6971A6A0-F0EA-4FF0-8BB1-DF3E91685F38Q38254295-4D1FDE91-B3B7-4DF5-90B4-A24A753AA499Q38636440-EEB5AAE0-7147-43C9-901C-D0DD42C90FBAQ38690406-3C2EA1EE-BBEB-497A-BF10-56A4D7F63F04Q38936296-471E8592-9455-4E53-9B7E-5C449466411C
P2860
Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@ast
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@en
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@nl
type
label
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@ast
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@en
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@nl
prefLabel
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@ast
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@en
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@nl
P2093
P1476
Topotecan versus observation a ...... rn Cooperative Oncology Group.
@en
P2093
P304
P356
10.1200/JCO.2001.19.8.2114
P407
P577
2001-04-01T00:00:00Z